Wei Tao, Harvard Medical School, Boston, USA
Prof. Wei Tao is a Farokhzad Family Distinguished Chair for Innovation and a Principal Investigator in the Center for Nanomedicine, and a Faculty Member in the Department of Anesthesiology, Perioperative, and Pain Medicine at Brigham and Women’s Hospital (BWH), Harvard Medical School (HMS). He is also the first Chaired Professor as an assistant professor in the history of his institution.
He has received multiple awards/grants including the U.S. METAvivor Early Career Investigator Award, HMS/BWH Anaesthesia Department Basic Scientist Grant, Khoury Innovation Award, Center for Nanomedicine Research Fund, Stepping Strong Breakthrough Innovator Award, American Heart Association (AHA) Collaborative Sciences Award, MIT Technology Review Top Chinese Innovators Under 35 (TR35), Clarivate’s Global Highly Cited Researchers List (2021), World’s Top 2% Scientists (from Mendeley Data, Elsevier; 2019, 2020), Microsoft Academic Global Top 5 Trending Authors in Nanotechnology (2016-2020) and Top Authors in Nanomedicine, Chemical Society Reviews (IF=54.564) Emerging Investigator, Materials Today (IF=31.041) Rising Star Award, Journal of Materials Chemistry A (IF=12.732) Emerging Investigator, Materials Horizons (IF=13.266) Top 10 Outstanding Reviewers, Nanoscale (IF=7.790) Emerging Investigator, Precision Nanomedicine Rising Talents, etc. He also serves on numerous editorial boards including as Associate Editor of Journal of Nanobiotechnology (IF=10.435; Springer Nature & BMC) and Exploration (Wiley), Editorial Board Member of Bioactive Materials (IF=14.593; Elsevier, KeAi), Nano-Micro Letters (IF=16.419; Springer Nature), and Advisory Board Member of Matter (IF=15.589; Cell Press).
Subject Keywords: biomaterials, nanotechnology, RNA medicine, drug delivery
Wei Chen, Harvard Medical School, Boston, USA
Xiangfei Han, Harvard Medical School, Boston, USA
Xiaoyuan Ji, Tianjin University, Tianjin, China
Zhongmin Tang, University of Wisconsin – Madison, Madison, WI, USA